Study guide
11.3 Thyroid Storm, Feline Hyperthyroid Crises & Severe Hypoglycemia
Veterinary Technician Specialist in Emergency and Critical Care VTS ECC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview, Triage & Point-of-Care Assessment
1.1 AVECCTN Examination Structure, Blueprint & Credentialing 1.2 Emergency Triage Systems, Primary Survey & Capsule Diagnostics 1.3 Point-of-Care Ultrasound (POCUS / TFAST / AFAST / VetBLUE) & Rapid Interventions
2 Chapter 2: Cardiovascular Emergencies & RECOVER CPR
2.1 RECOVER Guidelines: Basic Life Support (BLS) & Resuscitation Dynamics 2.2 Advanced Life Support (ALS): Emergency Pharmacopeia, Reversals & Defibrillation 2.3 Electrocardiogram (ECG) Interpretation & Antiarrhythmic Therapy 2.4 Congestive Heart Failure, Cardiac Tamponade & Feline Aortic Thromboembolism
3 Chapter 3: Fluid Therapy, Shock Resuscitation & Acid-Base Balance
3.1 Pathophysiology, Stages & Classification of Shock 3.2 Fluid Dynamics, Crystalloids, Colloids & Hypertonic Resuscitation 3.3 Electrolyte Disorders: Potassium, Sodium, Calcium & Phosphorus 3.4 Arterial & Venous Blood Gas Analysis & Acid-Base Disorders
4 Chapter 4: Respiratory Emergencies & Mechanical Ventilation
4.1 Upper Airway Obstruction: BOAS, Laryngeal Paralysis & Tracheal Collapse 4.2 Lower Airway, Pulmonary Parenchymal & Vascular Emergencies: Asthma, Contusions & ARDS 4.3 Pleural Space Disease, Emergency Thoracocentesis & Chest Tube Management 4.4 Oxygen Delivery Modalities, Capnography & Mechanical Ventilation Basics
5 Chapter 5: Gastrointestinal & Hepatic Emergencies
5.1 Gastric Dilatation-Volvulus (GDV): Resuscitation, Decompression & Critical Nursing 5.2 Acute Abdomen, Septic Peritonitis & Canine Parvoviral Enteritis 5.3 Acute Pancreatitis, Acute Hemorrhagic Diarrhea Syndrome & Mesenteric Volvulus 5.4 Acute Hepatic Failure, Hepatic Encephalopathy & Biliary Emergencies
6 Chapter 6: Anesthesia, Analgesia & Constant Rate Infusions
6.1 Emergency Anesthesia Protocols & High-Risk Patient Stabilization 6.2 Multimodal Analgesia, Pain Scoring Scales & Local/Regional Anesthesia 6.3 Constant Rate Infusions (CRIs): Formulations, Calculations & Monitoring 6.4 Anesthetic Complications: Hypotension, Hypothermia & Emergency Interventions
7 Chapter 7: Renal & Urinary Emergencies
7.1 Acute Kidney Injury (AKI): Pathophysiology, IRIS Staging & Renal Replacement Therapy 7.2 Feline Urethral Obstruction: Deobstruction, Electrolyte Crises & Post-Obstructive Diuresis 7.3 Uroabdomen & Lower Urinary Tract Trauma: Diagnosis & Resuscitation
8 Chapter 8: Hemolymphatic, Transfusion Medicine & Sepsis/SIRS
8.1 Transfusion Medicine: Blood Typing, Crossmatching & Component Therapy 8.2 Immune-Mediated Hemolytic Anemia (IMHA) & Immune-Mediated Thrombocytopenia (IMTP) 8.3 Sepsis, Systemic Inflammatory Response Syndrome (SIRS) & DIC 8.4 Oncologic Emergencies: Tumor Lysis Syndrome, Bleeding Masses & Hypercalcemia
9 Chapter 9: Environmental, Toxicological, Ophthalmic & Exotic Species Emergencies
9.1 Heatstroke, Severe Hypothermia & Thermal Burn Management 9.2 Envenomation Syndromes & Acute Anaphylaxis Management 9.3 Common Small Animal Toxicities: Chocolate, Xylitol, NSAIDs & Rodenticides 9.4 Neurotoxins, Ethylene Glycol, Plant Toxins & Extracorporeal Therapies 9.5 Ophthalmologic Emergencies: Proptosis, Acute Glaucoma, Corneal Perforation & Chemical Injury 9.6 Emergency Care of Exotic Companion Species: Rabbits, Rodents, Ferrets, Birds & Reptiles
10 Chapter 10: Neurological Emergencies
10.1 Status Epilepticus & Cluster Seizures: Emergency Protocols & Refractory Therapy 10.2 Traumatic Brain Injury (TBI), Intracranial Pressure (ICP) & Modified Glasgow Coma Scale 10.3 Acute Spinal Cord Emergencies: Intervertebral Disc Disease (IVDD) & Neuro-Localization
11 Chapter 11: Endocrine & Metabolic Crises
11.1 Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) 11.2 Acute Adrenocortical Crisis (Addisonian Crisis) & Hypoadrenocorticism 11.3 Thyroid Storm, Feline Hyperthyroid Crises & Severe Hypoglycemia
12 Chapter 12: Reproductive & Musculoskeletal Emergencies
12.1 Reproductive Emergencies: Dystocia, Pyometra & Puerperal Hypocalcemia 12.2 Musculoskeletal Trauma: Open Fractures, Luxations, Splints & Compartment Syndrome 12.3 Rhabdomyolysis, Crush Injury & Polytrauma Damage Control Resuscitation
13 Chapter 13: Advanced Critical Care Monitoring, Vascular Access & The Rule of 20
13.1 Central Venous Catheterization, Arterial Lines & Intraosseous Access 13.2 Hemodynamic Monitoring: Invasive vs. Non-Invasive Blood Pressure, CVP & Cardiac Output 13.3 Kirby's Rule of 20: Comprehensive Daily Critical Patient Evaluation Checklist
11.3 Thyroid Storm, Feline Hyperthyroid Crises & Severe Hypoglycemia
Key Takeaways Explain This Topic AI
Feline thyroid storm is a life-threatening hypermetabolic crisis in hyperthyroid cats characterized by massive acute surges of free T3/T4, dramatic upregulation of beta-adrenergic receptors, malignant hyperthermia (>105°F), malignant tachyarrhythmias (>240 bpm), severe hypertension, and acute congestive heart failure.
Emergency stabilization of thyroid storm demands immediate adrenergic blockade with ultra-short-acting beta-blockers (Esmolol CRI 25-200 mcg/kg/min or Atenolol), anti-thyroid synthesis inhibition (Methimazole), gentle evaporative cooling, minimal stress handling, and strict avoidance of aggressive fluid overload.
Severe hypoglycemia (<50-60 mg/dL) produces neuroglycopenia (ataxia, disorientation, blindness, tremors, status epilepticus, and coma) due to the brain's absolute dependence on continuous glucose delivery via non-insulin-dependent GLUT-1/GLUT-3 transporters.
Key critical differentials for hypoglycemia include sepsis/SIRS (massive peripheral consumption), canine insulinoma (functional beta-cell neoplasia), xylitol toxicosis (6-8x exaggerated insulin release), toy breed juvenile hypoglycemia, and Addison's disease.
Emergency hypoglycemia management requires slow IV administration of 50% Dextrose (0.5-1.0 mL/kg diluted 1:1 or 1:2 to prevent chemical thrombophlebitis), followed immediately by a 2.5-5.0% dextrose CRI to prevent rebound reactive hypoglycemia; refractory cases benefit from Glucagon CRI (5-10 ng/kg/min).
Last updated: August 2026
Thyroid Storm, Feline Hyperthyroid Crises & Severe Hypoglycemia
VTS Critical Concept: Endocrine hyper- and hypo-metabolic emergencies present dramatic physiological extremes. Feline thyroid storm represents an explosive surge in thyroid hormone activity combined with massive sympathetic β \beta β -adrenergic hypersensitivity, where aggressive IV fluid therapy can precipitate fatal pulmonary edema. In contrast, severe hypoglycemia deprives the central nervous system of its primary metabolic substrate, demanding rapid hypertonic dextrose dilution, constant rate infusion to prevent rebound hypoglycemia, and adjunctive Glucagon CRI for refractory neuroendocrine crises.
1. Pathophysiology of Feline Thyroid Storm & Thyrotoxicosis
Thyroid Storm is an acute, life-threatening decompensation of thyrotoxicosis encountered in geriatric cats with underlying functional thyroid adenomatous hyperplasia or thyroid carcinoma. [ Acute Surge of Free T3 / T4 + Massive Adrenergic Receptor Hypersensitization ]
- │
- ┌───────────────────────────┴───────────────────────────┐
- ▼ ▼
- [ Extreme Hypermetabolism & Thermogenesis ] [ Cardiovascular Beta-Receptor Stimulation ]
- Uncoupling of oxidative phosphorylation • Upregulation of β1 & β2 adrenergic receptors
- Massive cellular oxygen consumption • Extreme tachycardia (HR > 240-260 bpm)
- Malignant hyperthermia (> 105.8°F / 41°C) • Malignant tachyarrhythmias (VPCs, V-Tach, A-Fib)
- Profound muscle catabolism & cachexia • Severe systemic hypertension (SBP > 180-220 mmHg)
- │ │
- └───────────────────────────┬───────────────────────────┘
- ▼
- [ High-Output Heart Failure ──► Cardiogenic Pulmonary Edema / Pleural Effusion ]
- [ Acute Retinal Detachment ──► Hyphema / Sudden Blindness ──► Delirium / Death ]
- Cellular Mechanisms of Thyroid Hormone Excess
Upregulation of Adrenergic Receptors: Thyroid hormones ( T 3 T_3 T 3 and T 4 T_4 T 4 ) dramatically increase the density and affinity of β 1 \beta_1 β 1 - and β 2 \beta_2 β 2 -adrenergic receptors on myocardial and vascular smooth muscle cells, creating an extreme hypersensitivity to normal or elevated levels of circulating catecholamines.
Uncoupling of Oxidative Phosphorylation: Excess T 3 T_3 T 3 stimulates mitochondrial inner membrane uncoupling proteins (UCPs) and upregulates cellular Na + / K + \text{Na}^+/\text{K}^+ Na + / K + -ATPase synthesis, converting cellular energy directly into massive amounts of thermal energy (malignant hyperthermia).
Thyrotoxic Cardiomyopathy: Chronic thyrotoxicosis induces concentric left ventricular hypertrophy (hypertrophic cardiomyopathy phenotype) and high-output circulatory failure. When thyroid storm occurs, extreme tachycardia shortens diastolic filling time, causing acute congestive heart failure ( cardiogenic pulmonary edema and pleural effusion ).
Precipitating Triggers
Thyroid storm rarely occurs spontaneously; it is typically precipitated by an acute stressor in a chronically hyperthyroid cat:
Severe non-thyroidal systemic illness (e.g., acute pancreatitis, diabetic ketoacidosis, systemic infection, acute kidney injury).
Vigorous palpation of the cervical thyroid region (rupture/leakage of thyroid follicles).
Radioiodine ( 131 I ^{131}\text{I} 131 I ) therapy or thyroidectomy surgery.
Abrupt withdrawal or discontinuation of chronic methimazole therapy.
General anesthesia or severe environmental stress.
Clinical Presentation: Classical vs. Apathetic Thyrotoxicosis
Classical Thyroid Storm Signs: Extreme malignant hyperthermia ( > 105.0 − 106.5 ∘ F / > 40.5 − 41.4 ∘ C >105.0-106.5^\circ\text{F}\ /\ >40.5-41.4^\circ\text{C} > 105.0 − 106. 5 ∘ F / > 40.5 − 41. 4 ∘ C ) , severe sinus tachycardia ( > 240 − 280 bpm >240-280\text{ bpm} > 240 − 280 bpm ), gallop rhythms, systolic murmurs, ventricular premature complexes (VPCs), paroxysmal ventricular tachycardia, atrial fibrillation, tachypnea, open-mouth panting, severe systemic hypertension (systolic BP > 180 − 220 mmHg >180-220\text{ mmHg} > 180 − 220 mmHg ), acute retinal hemorrhage/detachment ( sudden blindness ), agitation, pacing, delirium, and sudden collapse.
Apathetic Thyrotoxicosis (10-15% of cases): An atypical presentation characterized by profound depression, severe lethargy, complete anorexia, marked muscle wasting, weakness, ventral neck flexion (secondary to hypokalemic polymyopathy), and paradoxically normal or subnormal body temperature (hypothermia) .
2. Emergency Management of Thyroid Storm
Resuscitation of thyroid storm requires a delicate balance between adrenergic blockade, anti-thyroid pharmacotherapy, cooling, and extreme fluid restraint.
Therapeutic Objective Drug / Intervention Dose & Administration Protocol Clinical Rationale & Critical Precaution
Adrenergic Blockade (Gold Standard) Esmolol (Ultra-short acting β 1 \beta_1 β 1 -blocker) Loading dose: 25 − 50 mcg/kg IV 25-50\text{ mcg/kg IV} 25 − 50 mcg/kg IV over 1 − 2 min 1-2\text{ min} 1 − 2 min ; then CRI: 25 − 200 mcg/kg/min 25-200\text{ mcg/kg/min} 25 − 200 mcg/kg/min Rapidly slows heart rate, reduces myocardial oxygen demand, and controls arrhythmias. Ultra-short half-life ( 9 min 9\text{ min} 9 min ) allows rapid discontinuation if heart failure worsens.
Adrenergic Blockade (Oral/Alternative) Atenolol 6.25 − 12.5 mg/cat PO q12-24h 6.25-12.5\text{ mg/cat PO q12-24h} 6.25 − 12.5 mg/cat PO q12-24h (or Propranolol 0.2 − 0.5 mg/kg PO q8h 0.2-0.5\text{ mg/kg PO q8h} 0.2 − 0.5 mg/kg PO q8h ) Long-acting oral β \beta β -blockade. Propranolol also uniquely inhibits peripheral conversion of T 4 T_4 T 4 to active T 3 T_3 T 3 .
Inhibition of Hormone Synthesis Methimazole 2.5 − 5.0 mg/cat PO, transdermal, or IV (compounded) q12h 2.5-5.0\text{ mg/cat PO, transdermal, or IV (compounded) q12h} 2.5 − 5.0 mg/cat PO, transdermal, or IV (compounded) q12h Inhibits thyroid peroxidase, blocking organification and synthesis of new thyroid hormones. Does not block release of pre-formed hormone.
Inhibition of Hormone Release Potassium Iodate / Sodium Ipodate Sodium ipodate: 15 mg/kg PO q12h 15\text{ mg/kg PO q12h} 15 mg/kg PO q12h (or Lugol's solution) Rapidly inhibits the release of pre-formed T 3 T_3 T 3 and T 4 T_4 T 4 from thyroid colloid via the Wolff-Chaikoff effect (administer ≥ 1 hr \ge 1\text{ hr} ≥ 1 hr after methimazole).
Active Cooling Protocols Tepid water mist & fans Apply room-temperature water with continuous fan airflow Evaporative cooling for core temp > 105 ∘ F >105^\circ\text{F} > 10 5 ∘ F . Halt cooling at 103.0 − 103.5 ∘ F 103.0-103.5^\circ\text{F} 103.0 − 103. 5 ∘ F . Never use ice baths (triggers shivering and vasoconstriction).
FLUID MANAGEMENT WARNING Extreme Fluid Restraint Conservative maintenance rates ( 1 − 2 mL/kg/hr 1-2\text{ mL/kg/hr} 1 − 2 mL/kg/hr ) only; NO SHOCK BOLUSES Cats have underlying hypertrophic cardiomyopathy. Standard fluid boluses trigger fatal acute pulmonary edema and pleural effusion .
3. Pathophysiology of Severe Hypoglycemia & Neuroglycopenia
Severe hypoglycemia is defined as blood glucose < 50 − 60 mg/dL <50-60\text{ mg/dL} < 50 − 60 mg/dL ( < 2.8 − 3.3 mmol/L <2.8-3.3\text{ mmol/L} < 2.8 − 3.3 mmol/L ) . The central nervous system is exceptionally vulnerable to glucose deprivation because the brain lacks endogenous glycogen stores and depends entirely on continuous glucose delivery across the blood-brain barrier via non-insulin-dependent glucose transporters (GLUT-1 on endothelial cells and GLUT-3 on neurons) . [ Blood Glucose < 50-60 mg/dL (2.8-3.3 mmol/L) ]
- │
- ┌──────────────┴──────────────┐
- ▼ ▼
- [ Autonomic Counter-Regulatory Surge ] [ Neuroglycopenia (Neuronal Fuel Starvation) ]
- Epinephrine & Norepinephrine release • Brain glucose extraction failure
- Glucagon & Cortisol elevation • Impaired neuronal ATP generation
- Tachycardia, anxiety, restlessness • Failure of cellular Na+/K+-ATPase pumps
- Peripheral vasoconstriction & hunger • Intracellular calcium influx & glutamate excitotoxicity
- │ │
- └──────────────┬──────────────┘
- ▼
- [ Disorientation ──► Ataxia ──► Cortical Blindness ──► Status Epilepticus ──► Coma / Brain Death ]
- Clinical Progression of Neuroglycopenia
Early Autonomic Phase ( 50 − 60 mg/dL 50-60\text{ mg/dL} 50 − 60 mg/dL ): Restlessness, pacing, intense hunger, trembling, sinus tachycardia, and dilated pupils.
Moderate Neuroglycopenic Phase ( 35 − 50 mg/dL 35-50\text{ mg/dL} 35 − 50 mg/dL ): Mental confusion, glassy-eyed stare, profound weakness, generalized ataxia, conscious proprioceptive deficits, and transient cortical blindness (loss of menace with intact pupillary light reflexes).
Severe Neuroglycopenic Crisis ( < 30 − 35 mg/dL <30-35\text{ mg/dL} < 30 − 35 mg/dL ): Focal facial myoclonus (lip-smacking, twitching), generalized tonic-clonic seizures, status epilepticus , stupor, coma, decerebrate posturing, and irreversible ischemic neuronal necrosis.
4. Critical Differential Diagnoses for Hypoglycemia
Etiological Category Disease / Condition Primary Pathophysiological Mechanism Diagnostic Clues & Key Features
Infectious / Sepsis Sepsis / Severe SIRS Massive peripheral glucose consumption by activated leukocytes and bacteria; endotoxin-mediated inhibition of hepatic gluconeogenesis Severe hypotension, hyperlactatemia, degenerative left shift, toxic neutrophils, focused T-FAST/A-FAST septic focus
Neoplastic Canine Insulinoma Autonomous, unregulated insulin hypersecretion by functional β \beta β -cell neuroendocrine tumors of the pancreas Middle-aged/older dogs (Boxers, Golden Retrievers); normal or elevated serum insulin in the presence of severe hypoglycemia ( < 60 mg/dL <60\text{ mg/dL} < 60 mg/dL )
Toxicological Xylitol (Birch Sugar) Toxicity Potent pancreatic secretagogue in dogs, stimulating a 6 − 8 × 6-8\times 6 − 8 × surge of endogenous insulin release independent of glucose levels Ingestion of sugar-free gums/candies/baked goods; rapid severe hypoglycemia ( 15 − 60 min 15-60\text{ min} 15 − 60 min post-ingestion) + risk of acute hepatic necrosis
Iatrogenic Exogenous Insulin Overdose Administration of excess intermediate or long-acting insulin (NPH, Vetsulin, Glargine) or accidental double-dosing Diabetic history, lack of food consumption following insulin administration, prolonged hypoglycemia
Developmental / Pediatric Toy Breed Juvenile Hypoglycemia Inadequate hepatic glycogen stores, small muscle mass, immature hepatic gluconeogenesis enzymes, hypothermia, stress Puppies < 6 months <6\text{ months} < 6 months (Yorkies, Chihuahuas, Malteses); precipitated by fasting, intestinal parasites, or cold exposure
Hepatic Failure End-Stage Cirrhosis / Portosystemic Shunt (PSS) Loss of > 70 − 80 % >70-80\% > 70 − 80% functional hepatic parenchyma, disabling both gluconeogenesis and glycogenolysis Severe microhepatica, elevated bile acids/ammonia, marked hypoalbuminemia, low BUN, ammonium urate crystalluria
Endocrine Hypoadrenocorticism (Addison's) Absence of cortisol removes permissive support for gluconeogenesis and increases peripheral insulin sensitivity Hyponatremia, hyperkalemia (Na:K < 20 : 1 <20:1 < 20 : 1 ), classic pre/post ACTH cortisol < 1 mcg/dL <1\text{ mcg/dL} < 1 mcg/dL
Loading diagram... Emergency Hypoglycemia Resuscitation & Refractory Algorithm
- 5. Emergency Hypoglycemia Resuscitation Protocols
- Step 1: Emergency IV Dextrose Bolus
Dosage: 50 % Dextrose (0.5 g/mL) 50\%\text{ Dextrose (0.5 g/mL)} 50% Dextrose (0.5 g/mL) at 0.5 − 1.0 mL/kg 0.5-1.0\text{ mL/kg} 0.5 − 1.0 mL/kg ( 0.25 − 0.5 g/kg IV 0.25-0.5\text{ g/kg IV} 0.25 − 0.5 g/kg IV ) .
MANDATORY DILUTION PROTOCOL: Never administer undiluted 50 % 50\% 50% dextrose through a peripheral IV catheter. Undiluted 50 % 50\% 50% dextrose has an osmolality of approximately 2 , 525 mOsm/L 2,525\text{ mOsm/L} 2 , 525 mOsm/L ( > 8 × >8\times > 8 × normal serum osmolality). Rapid peripheral injection causes severe chemical thrombophlebitis, endothelial necrosis, and severe tissue sloughing if extravasation occurs. Always dilute 1 : 1 1:1 1 : 1 with sterile 0.9 % saline 0.9\%\text{ saline} 0.9% saline or sterile water to create a 25 % 25\% 25% solution , or 1 : 2 1:2 1 : 2 to create a 16.7 % 16.7\% 16.7% solution , and infuse slowly over 5 − 10 minutes 5-10\text{ minutes} 5 − 10 minutes .
Oral Transmucosal Dextrose / Karo Syrup: If IV access cannot be immediately established in an actively seizing patient at home or during triage, apply a small amount of concentrated corn syrup (Karo syrup) or 50 % 50\% 50% dextrose directly to the oral buccal mucosa. Caution: Never administer large liquid volumes into the pharynx of an unconscious or seizing animal due to the extreme risk of fatal pulmonary aspiration.
Step 2: Continuous Dextrose Maintenance (Preventing Rebound Hypoglycemia)
An intravenous hypertonic dextrose bolus stimulates a secondary compensatory wave of endogenous insulin release from the pancreas. In patients with an insulinoma or xylitol toxicosis , this triggers massive rebound reactive hypoglycemia , driving blood glucose even lower than initial presentation.
Protocol: Immediately follow the initial dextrose bolus with a constant rate infusion of 2.5 % 2.5\% 2.5% to 5.0 % 5.0\% 5.0% Dextrose in balanced isotonic crystalloids .
To make 2.5 % 2.5\% 2.5% Dextrose: Add 50 mL 50\text{ mL} 50 mL of 50 % 50\% 50% dextrose to 950 mL 950\text{ mL} 950 mL of fluids.
To make 5.0 % 5.0\% 5.0% Dextrose: Add 100 mL 100\text{ mL} 100 mL of 50 % 50\% 50% dextrose to 900 mL 900\text{ mL} 900 mL of fluids.
Step 3: Refractory Hypoglycemia & Glucagon CRI
When patients with functional insulinomas, massive xylitol ingestions, or severe long-acting insulin overdoses fail to maintain euglycemia ( > 70 − 80 mg/dL >70-80\text{ mg/dL} > 70 − 80 mg/dL ) despite 5 − 10 % 5-10\% 5 − 10% dextrose infusions:
Glucagon Constant Rate Infusion (CRI):
Mechanism: Glucagon binds to specific G-protein coupled receptors on hepatocytes, activating adenylate cyclase to generate cyclic AMP (cAMP). This directly stimulates hepatic glycogenolysis and gluconeogenesis while inhibiting glycolysis, completely bypassing insulin receptor blockade.
Dosing: Administer an IV loading dose of 5 ng/kg 5\text{ ng/kg} 5 ng/kg , followed by a CRI starting at 5 − 10 ng/kg/min 5-10\text{ ng/kg/min} 5 − 10 ng/kg/min , titrated upward to 15 − 20 ng/kg/min 15-20\text{ ng/kg/min} 15 − 20 ng/kg/min based on serial blood glucose monitoring.
Glucocorticoid Therapy: Administer Dexamethasone Sodium Phosphate ( 0.1 − 0.2 mg/kg IV q12-24h 0.1-0.2\text{ mg/kg IV q12-24h} 0.1 − 0.2 mg/kg IV q12-24h ) . Glucocorticoids induce hepatic gluconeogenic enzymes (phosphoenolpyruvate carboxykinase) and inhibit peripheral GLUT-4 translocation in skeletal muscle and adipose tissue, promoting peripheral insulin resistance.
Anticonvulsant Therapy: If seizures persist despite restoring blood glucose > 80 mg/dL >80\text{ mg/dL} > 80 mg/dL , administer Midazolam ( 0.2 − 0.5 mg/kg IV 0.2-0.5\text{ mg/kg IV} 0.2 − 0.5 mg/kg IV ) or Levetiracetam ( 60 mg/kg IV 60\text{ mg/kg IV} 60 mg/kg IV ) to control secondary neuroglycopenic seizure foci and prevent ongoing cerebral metabolic exhaustion.